@FierceBiotech: 'Hitchhiking' gold nanostars can sneak into cancer cells. More | Follow @FierceBiotech
@JohnCFierce: With Lipitor and Plavix out of the top 10, Abbott's Humira will take the top spot among best-sellers. Article | Follow @JohnCFierce
@RyanMFierce: An Arkansas jury rules against $JNJ in Risperdal marketing case, state AG says J&J 'lied.' Story | Follow @RyanMFierce
> Globes reports that incoming Teva ($TEVA) CEO Jeremy Levin (photo) is taking some time to carefully review the pharma company's pipeline of experimental therapies. Levin, a veteran deal-maker at Bristol-Myers Squibb ($BMY), was brought in to beef up the company's work on novel drugs. Report
> AcelRx Pharmaceuticals has won key patents on its methods for controlling post-operative pain. Story
> China's Lotus Pharmaceuticals, a penny stock biotech company based in Beijing, says it has had to stop construction of a new headquarters after running into an unexpected cash crunch. In its release, the company made an appeal for new financing. Release
Pharma News
@FiercePharma: WSJ previews Q1 earnings. Gist: Patent cliff rules. Pfizer's 1st full Q with Lipitor rivals, Lilly's with Zyprexa. More | Follow @FiercePharma
> UPDATED: Judge hits J&J with $1.1B penalty in Risperdal case. News
> Takeda snaps up URL Pharma in $800M+ deal. Story
> Humira takes top spot in drug sales. More
> FDA adds clotting data to Bayer's Yaz, Yasmin. Article
Medical Devices News
@FierceMedDev: Tough luck, St. Jude: No retraction for you. News | Follow @FierceMedDev
> Ex-Orthofix VP pleads guilty over kickback. Article
> Report: Diabetes Dx market to hit $32B by 2017. More
> GE touts good early data for Alzheimer's imaging Dx. Story
> Board urges evaluation of device hacking risks. Item
Biomarkers News
> Genomic sequencing--is it of value? Commentary
> Lung metastasis may be marked by tumor cell protein. More
> Scientists seek breast cancer biomarkers in a drop of blood. Article
> ARISk launched to screen for sibling autism risk. News
> Proteome Sciences shares jump on licensing deal. Item
Drug Delivery News
> Bind touts positive results for cancer-fighting nanoparticles. Article
> Natural mucoadhesive tablet delivers anti-cancer spice. Story
> Liquidia CEO: Nanotech will outpace biotech. More
> Is reformulation discouraging innovation? Piece
And Finally…Women undergoing treatment for breast cancer can experience cognitive declines, such as decreased verbal fluency or loss of memory and attention, according to a new study from the University of Missouri. Release